Global Pharmaceuticals & Biotech Undervalued Small Caps

Zevra Therapeutics

Market Cap: US$496.0m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

Hugel

Market Cap: ₩2.5t

Develops and manufactures biopharmaceuticals in South Korea and internationally.

Zhejiang Jolly PharmaceuticalLTD

Market Cap: CN¥11.2b

Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.

Abeona Therapeutics

Market Cap: US$280.7m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

Genomma Lab Internacional. de

Market Cap: Mex$17.4b

Provides pharmaceutical and personal care products primarily in Mexico and internationally.

Consun Pharmaceutical Group

Market Cap: HK$13.1b

Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.

China Resources Boya Bio-pharmaceutical GroupLtd

Market Cap: CN¥11.4b

Engages in the blood product businesses in China.

Beijing Strong BiotechnologiesInc

Market Cap: CN¥7.6b

Researches, develops, manufactures, and sells in-vitro diagnostics (IVD) products and services in China and internationally.

Wuhan Hvsen BiotechnologyLtd

Market Cap: CN¥4.2b

Engages in the research and development, and manufacture of macrolides APIs and preparations in China and internationally.

Essex Bio-Technology

Market Cap: HK$2.1b

An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.

SIGA Technologies

Market Cap: US$441.8m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

IOL Chemicals and Pharmaceuticals

Market Cap: ₹24.1b

Manufactures and sells pharmaceutical and chemical products in India and internationally.

Jiangsu Sinopep-Allsino Biopharmaceutical

Market Cap: CN¥11.9b

A biomedical company, engages in the research and development, production, and sale of peptides, oligonucleotides, and small molecule drugs in China.

Pharming Group

Market Cap: €977.0m

A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.

Photocure

Market Cap: NOK 1.9b

Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.

Strides Pharma Science

Market Cap: ₹84.0b

Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, and internationally.

Faes Farma

Market Cap: €1.6b

Researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally.

Newron Pharmaceuticals

Market Cap: CHF 476.1m

A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.

Niagen Bioscience

Market Cap: US$519.0m

Operates as a bioscience company engages in developing healthy aging products.

Beijing Kawin Technology Share-Holding

Market Cap: CN¥4.2b

A biopharmaceutical company, provides treatment solutions for viral and immune diseases in China and internationally.

Medtide

Market Cap: HK$4.3b

A contract research, development, and manufacturing company, provides early-stage discovery, preclinical research, clinical development, and commercial-stage production services.

Blue Jet Healthcare

Market Cap: ₹91.8b

Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.

Tong Ren Tang Technologies

Market Cap: HK$5.6b

Produces and distributes Chinese medicine products in Mainland China and Hong Kong.

Fine Foods & Pharmaceuticals N.T.M

Market Cap: €234.2m

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

BioGaia

Market Cap: SEK 10.7b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

Pacific Shuanglin Bio-pharmacy

Market Cap: CN¥13.0b

Engages in research, development, production, and sales of blood products in China and internationally.

Zeria Pharmaceutical

Market Cap: JP¥92.5b

Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally.

MiMedx Group

Market Cap: US$1.0b

Develops and distributes placental tissue allografts for various sectors of healthcare.

Akums Drugs and Pharmaceuticals

Market Cap: ₹68.3b

Manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally.

Alivus Life Sciences

Market Cap: ₹111.3b

Develops, manufactures, and markets active pharmaceutical ingredients in India, Japan, Europe, North and Latin America, and internationally.

Marksans Pharma

Market Cap: ₹81.5b

Engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally.